- Reuters•10 hours ago
Drugmaker Perrigo Co Plc said on Monday it agreed to sell the royalty stream from its multiple sclerosis drug Tysabri to privately held Royalty Pharma for up to $2.85 billion. Perrigo said it would delay the filing of its annual report until March, and would review past accounting practices, specifically its historical revenue recognition of its Tysabri sales. The company also said its chief financial officer, Judy Brown, was stepping down, to be replaced by an interim finance head.
- Motley Fool•2 days ago
Amgen, Consolidated Edison, and Kinder Morgan are high-quality, low-stress stocks worth investing in for the long term.
- Investor's Business Daily•4 days ago
AbbVie is a stronger stock bet than Gilead Sciences and Amgen, Leerink analyst Geoffrey Porges said Thursday.
AMGN : Summary for Amgen Inc. - Yahoo Finance
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||175.66 x 400|
|Ask||176.67 x 100|
|Day's Range||173.71 - 176.25|
|52 Week Range||133.64 - 176.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||17.20|
|Dividend & Yield||4.60 (2.64%)|
|1y Target Est||N/A|